Work

Aberrant p53 expression predicts clinical resistance to cisplatin-based chemotherapy in locally advanced non-small cell lung cancer.

Year: 1995

Type: article

Source: PubMed

Authors: V Rusch, D Klimstra, E Venkatraman, J Oliver, N Martini, R Gralla, M Kris, E Dmitrovsky

Institutions: Memorial Sloan Kettering Cancer Center, Tulane University

Language: English

Topic: Lung Cancer Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2151844294

FWCI: 16.29

Cites: 21

Cited by: 194

Related to: 10